SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-344161
Filing Date
2012-08-08
Accepted
2012-08-08 16:37:34
Documents
3
Period of Report
2012-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d393600d8k.htm 8-K 20355
2 PRESS RELEASE ISSUED AUGUST 2, 2012 d393600dex991.htm EX-99.1 8012
3 GRAPHIC g393600g68p34.jpg GRAPHIC 5236
  Complete submission text file 0001193125-12-344161.txt   37145
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34641 | Film No.: 121017304
SIC: 2834 Pharmaceutical Preparations